The role of nanotechnology-based approaches for clinical infectious diseases and public health
Given the high incidence of infection and the growing resistance of bacterial and viral infections to the traditional antiseptic, the need for novel antiseptics is critical. Therefore, novel approaches are urgently required to reduce the activity of bacterial and viral infections. Nanotechnology is...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-04-01
|
| Series: | Frontiers in Bioengineering and Biotechnology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1146252/full |
| _version_ | 1797854169869058048 |
|---|---|
| author | Xuefang Chen Jinfang Xu Bangju Ji Xingliang Fang Ketao Jin Jun Qian |
| author_facet | Xuefang Chen Jinfang Xu Bangju Ji Xingliang Fang Ketao Jin Jun Qian |
| author_sort | Xuefang Chen |
| collection | DOAJ |
| description | Given the high incidence of infection and the growing resistance of bacterial and viral infections to the traditional antiseptic, the need for novel antiseptics is critical. Therefore, novel approaches are urgently required to reduce the activity of bacterial and viral infections. Nanotechnology is increasingly being exploited for medical purposes and is of significant interest in eliminating or limiting the activity of various pathogens. Due to the increased surface-to-volume ratio of a given mass of particles, the antimicrobial properties of some naturally occurring antibacterial materials, such as zinc and silver, increase as particle size decreases into the nanometer regime. However, the physical structure of a nanoparticle and the way it interacts with and penetrates the bacteria also appear to provide unique bactericidal mechanisms. To measure the efficacy of nanoparticles (diameter 100 nm) as antimicrobial agents, it is necessary to comprehend the range of approaches for evaluating the viability of bacteria; each of them has its advantages and disadvantages. The nanotechnology-based disinfectants and sensors for SARS-CoV-2 provide a roadmap for creating more effective sensors and disinfectants for detecting and preventing coronaviruses and other infections. Moreover, there is an increasing role of nanotechnology-based approaches in various infections, including wound healing and related infection, nosocomial infections, and various bacterial infections. To meet the demand for patient care, nanotechnology-based disinfectants need to be further advanced with optimum approaches. Herein, we review the current burden of infectious diseases with a focus on SARS-CoV-2 and bacterial infection that significantly burdens developed healthcare systems and small healthcare communities. We then highlight how nanotechnology could aid in improving existing treatment modalities and diagnosis of those infectious agents. Finally, we conclude the current development and future perspective of nanotechnology for combating infectious diseases. The overall goal is to update healthcare providers on the existing role and future of nanotechnology in tackling those common infectious diseases. |
| first_indexed | 2024-04-09T20:01:25Z |
| format | Article |
| id | doaj.art-f03938bf58e546eeab84406fef5727da |
| institution | Directory Open Access Journal |
| issn | 2296-4185 |
| language | English |
| last_indexed | 2024-04-09T20:01:25Z |
| publishDate | 2023-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Bioengineering and Biotechnology |
| spelling | doaj.art-f03938bf58e546eeab84406fef5727da2023-04-03T04:35:40ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852023-04-011110.3389/fbioe.2023.11462521146252The role of nanotechnology-based approaches for clinical infectious diseases and public healthXuefang Chen0Jinfang Xu1Bangju Ji2Xingliang Fang3Ketao Jin4Jun Qian5Department of Clinical Laboratory, Affiliated Hospital of Shaoxing University, Shaoxing, ChinaDepartment of Emergency Medicine, Affiliated Hospital of Shaoxing University, Shaoxing, ChinaDepartment of Colorectal Surgery, Shaoxing People’s Hospital, Shaoxing, ChinaDepartment of Hepatobiliary Surgery, Affiliated Hospital of Shaoxing University, Shaoxing, ChinaDepartment of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, ChinaDepartment of Colorectal Surgery, Xinchang People’s Hospital, Affiliated Xinchang Hospital, Wenzhou Medical University, Xinchang, ChinaGiven the high incidence of infection and the growing resistance of bacterial and viral infections to the traditional antiseptic, the need for novel antiseptics is critical. Therefore, novel approaches are urgently required to reduce the activity of bacterial and viral infections. Nanotechnology is increasingly being exploited for medical purposes and is of significant interest in eliminating or limiting the activity of various pathogens. Due to the increased surface-to-volume ratio of a given mass of particles, the antimicrobial properties of some naturally occurring antibacterial materials, such as zinc and silver, increase as particle size decreases into the nanometer regime. However, the physical structure of a nanoparticle and the way it interacts with and penetrates the bacteria also appear to provide unique bactericidal mechanisms. To measure the efficacy of nanoparticles (diameter 100 nm) as antimicrobial agents, it is necessary to comprehend the range of approaches for evaluating the viability of bacteria; each of them has its advantages and disadvantages. The nanotechnology-based disinfectants and sensors for SARS-CoV-2 provide a roadmap for creating more effective sensors and disinfectants for detecting and preventing coronaviruses and other infections. Moreover, there is an increasing role of nanotechnology-based approaches in various infections, including wound healing and related infection, nosocomial infections, and various bacterial infections. To meet the demand for patient care, nanotechnology-based disinfectants need to be further advanced with optimum approaches. Herein, we review the current burden of infectious diseases with a focus on SARS-CoV-2 and bacterial infection that significantly burdens developed healthcare systems and small healthcare communities. We then highlight how nanotechnology could aid in improving existing treatment modalities and diagnosis of those infectious agents. Finally, we conclude the current development and future perspective of nanotechnology for combating infectious diseases. The overall goal is to update healthcare providers on the existing role and future of nanotechnology in tackling those common infectious diseases.https://www.frontiersin.org/articles/10.3389/fbioe.2023.1146252/fullnanotechnologyantisepticintensive care unitICUSARS-CoV-2 (2019-nCoV)bio-kil |
| spellingShingle | Xuefang Chen Jinfang Xu Bangju Ji Xingliang Fang Ketao Jin Jun Qian The role of nanotechnology-based approaches for clinical infectious diseases and public health Frontiers in Bioengineering and Biotechnology nanotechnology antiseptic intensive care unit ICU SARS-CoV-2 (2019-nCoV) bio-kil |
| title | The role of nanotechnology-based approaches for clinical infectious diseases and public health |
| title_full | The role of nanotechnology-based approaches for clinical infectious diseases and public health |
| title_fullStr | The role of nanotechnology-based approaches for clinical infectious diseases and public health |
| title_full_unstemmed | The role of nanotechnology-based approaches for clinical infectious diseases and public health |
| title_short | The role of nanotechnology-based approaches for clinical infectious diseases and public health |
| title_sort | role of nanotechnology based approaches for clinical infectious diseases and public health |
| topic | nanotechnology antiseptic intensive care unit ICU SARS-CoV-2 (2019-nCoV) bio-kil |
| url | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1146252/full |
| work_keys_str_mv | AT xuefangchen theroleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth AT jinfangxu theroleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth AT bangjuji theroleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth AT xingliangfang theroleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth AT ketaojin theroleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth AT junqian theroleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth AT xuefangchen roleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth AT jinfangxu roleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth AT bangjuji roleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth AT xingliangfang roleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth AT ketaojin roleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth AT junqian roleofnanotechnologybasedapproachesforclinicalinfectiousdiseasesandpublichealth |